View in Other Languages

Prescient Therapeutics Ltd


Prescient Therapeutics Limited is a clinical-stage oncology company. The Company's principal activities include in-licensing of intellectual property; the preparation for and conduct of clinical trials relating to the Company's products; business development associated with the promotion of its technologies and products, and business development associated with developing collaborative, partnership relationships and corporate transactions.



Australian Market Report of February 14, 2011: Black Fire Minerals (ASX:BFE) To Acquire Tungsten/Copper Project in USA

🕔2/14/2011 12:20:00 PM 12170

Australian Market Report of February 14, 2011 includes: Black Fire Minerals Limited (ASX:BFE) is to acquire 100% of the advanced Pilot Mountain Tungsten-Copper Project in Nevada, USA; Virax Holdings Limited (ASX:VHL) is to develop a novel skin cancer product; Southern Cross Goldfields Limited (ASX:SXG) discovered near-surface high-grade gold deposits in Western Australia; Prosperity Resources Limited (ASX:PSP) commenced gold drilling in Indonesia.

Read Full Article

Virax Holdings Limited ASX: VHL - Commencement of Phase II US trials - Dr David Beames, CEO

🕔11/20/2006 9:19:00 AM 3620

Virax Holdings Limited (ASX: VHL) - Commencement of Phase II US trials - Dr David Beames, CEO; Boardroomradio is pleased to announce that Virax Holdings Limited (ASX: VHL) has published an audio file.

Read Full Article

Aegis Equities Research Announce Health and Life Science Review, August 2006

🕔8/15/2006 2:42:55 PM 13219

The August 2006 edition of our Health & Life Science Quarterly Blue Book profiles niche life sciences companies, with a focus on company strategies, key projects and significant milestones.

Read Full Article


  • This Page Viewed: (Last 7 Days: 14) (Last 30 Days: 43) (Since Published: 11534) 

Company Data

  • (03) 9853 5134 
  • Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology 
  • Listed
  • 1986/12/19 
  • Homepage

Social Media